Iterum Therapeutics Plc

(OTC) ITRMF

Current Price$0.00

Market CapN/A

Since IPO (2018)-100%

5 Year-100%

1 Year+0%

1 Month-99%

Iterum Therapeutics Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$390.00K

Net Income (TTM)

$26.96M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ITRMF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Iterum Therapeutics Plc

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Dublin, D01 C4E0, IE

ITRMF Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-52%

Net Income Margin

-69%

Return on Equity

Return on Capital

-78%

Return on Assets

-83%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$254.00K

Operating Income

$18.70M

EBITDA

$21.73M

Operating Cash Flow

$26.77M

Capital Expenditure

$2.00K

Free Cash Flow

$26.77M

Cash & ST Invst.

$24.13M

Total Debt

$45.53M

Iterum Therapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$390.00K

N/A

Gross Profit

$370.00K

N/A

Gross Margin

94.87%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$8.98M

-47.3%

EBITDA

$8.05M

-50.2%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$22.73M

-186.5%

Accounts Receivable

$546.00K

N/A

Inventory

$1.15M

N/A

Long Term Debt

$33.45M

+283.3%

Short Term Debt

$281.00K

-98.0%

Return on Assets

-82.95%

N/A

Return on Invested Capital

-77.82%

N/A

Free Cash Flow

$7.86M

-194.2%

Operating Cash Flow

$7.85M

-193.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$5.15-0.39%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.62-0.61%

RLYBRallybio Corporation

RLYBRallybio Corporation$8.88+0.91%

PLURPluri Inc.

PLURPluri Inc.$3.42+1.48%

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$4.68-1.27%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.45+0.69%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.75+0.12%

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

NOKNokia

NOKNokia$12.46+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

HOODRobinhood Markets

HOODRobinhood Markets$71.20-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.67+0.39%

Questions About ITRMF

What is the current price of Iterum Therapeutics Plc?

Iterum Therapeutics Plc is trading at N/A per share.

What is the 52-week range for Iterum Therapeutics Plc?

Over the past 52 weeks, Iterum Therapeutics Plc has traded between N/A and N/A.

How much debt does Iterum Therapeutics Plc have?

Iterum Therapeutics Plc total debt is unavailable.

How much cash does Iterum Therapeutics Plc have on hand?

Iterum Therapeutics Plc does not have cash on hand data available.

What is Iterum Therapeutics Plc’s dividend yield?

Iterum Therapeutics Plc does not currently have a dividend yield.

Iterum Therapeutics Plc

Iterum Therapeutics Plc Financials at a Glance

ITRMF News

ITRM Reports Results

Why Iterum Therapeutics Stock Is Crashing Today

Why Iterum Therapeutics Stock Soared Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Iterum Therapeutics Plc

ITRMF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Iterum Therapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ITRMF

What is the current price of Iterum Therapeutics Plc?

What is the 52-week range for Iterum Therapeutics Plc?

How much debt does Iterum Therapeutics Plc have?

How much cash does Iterum Therapeutics Plc have on hand?

What is Iterum Therapeutics Plc’s dividend yield?

Premium Investing Services